GlassScriptPhysician profile
Aditya Jain
NPI 1821102641
$532.36
in general payments reported to CMS, 2019-2025
15 companies · $18.85 in 2025
The $18.85 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59.69 · 2020: $39.88 · 2021: $123 · 2022: $45.62 · 2023: $211 · 2024: $34.21 · 2025: $18.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $264.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $155.66 | 2023 | Micra |
| Biotronik INC. | $80.91 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $36.27 | 2019-2021 | |
| Kiniksa Pharmaceuticals International, Plc | $34.21 | 2024 | Arcalyst |
| Philips North America LLC | $33.92 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $33.79 | 2021 | |
| Impulse Dynamics (USA) INC. | $28.50 | 2022 | |
| Abbott Laboratories | $25.00 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $21.46 | 2023 | Arcalyst |
| Cook Medical LLC | $18.85 | 2025 | Advance, Cook Celect |
| Chiesi USA, INC. | $17.12 | 2022 | |
| Medtronic Vascular, INC. | $13.46 | 2019 | |
| Novartis Pharmaceuticals Corporation | $11.25 | 2020 | |
| Portola Pharmaceuticals, LLC | $11.00 | 2019 | |
| Pfizer INC. | $10.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aditya Jain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.